At a glance
- Originator Schering-Plough
- Class Antiallergics; Antiasthmatics; Antihistamines; Antiplatelets
- Mechanism of Action Histamine receptor antagonists; Platelet activating factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma